Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Regenerus Limited

Explore full profile

Advanced functional and diagnostic testing for healthcare practitioners

Edinburgh, United KingdomFounded 2012Biotech & Life Sciences
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Regenerus Limited and the history behind them.

About Regenerus Limited

Regenerus Labs is a distributor of advanced health tests for healthcare practitioners primarily in the UK and EU. Founded by Justin Price in 2012, the company's objective is to simplify the process of ordering and interpreting specialized functional and diagnostic tests for practitioners and their patients. Price, who has over 17 years of experience in the health sector, identified an opportunity in the functional health market and established the company to address it.

The company provides access to over 300 tests from more than 20 international laboratories. These tests cover areas such as gastrointestinal health, endocrinology, nutritional analysis, and environmental exposure. Regenerus Labs operates as a partner to healthcare professionals, offering a client management platform that facilitates test ordering, result tracking, and patient communication. The business model is B2B, serving a client base of General Practitioners, nutritionists, dietitians, and other health professionals. Revenue is generated by distributing tests and providing related support services. The platform also includes educational resources and clinical training to help practitioners effectively use the tests.

In June 2023, Regenerus Labs was acquired by Omnos, a digital health company that offers personalized health assessments by combining diagnostic tests with data-driven recommendations. Following the acquisition, Justin Price became a Board Director at Omnos. The merger aimed to integrate Regenerus' extensive test distribution network with Omnos' technology platform to enhance patient care and outcomes. The combined entity focuses on transforming health data into actionable insights for personalized care plans.

Source: Dealroom company data

At a glance

Founded
2012
Headquarters
Edinburgh, United Kingdom
Sector
Biotech & Life Sciences

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

  • Foresight Group
  • Scottish Enterprise Growth Investments
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇬🇧 United Kingdom · Edinburgh HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Regenerus Limited on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Regenerus Limited on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.